Imbalance between genomic gain and loss identifies high-risk neuroblastoma patients with worse outcomes

Survival in high-risk neuroblastoma (HR-NB) patients remains poor despite multimodal treatment. We aimed to identify HR-NB patients with worse outcomes by analyzing the genomic instability derived from segmental chromosomal aberrations. We calculated 3 genomic instability indexes for primary tumor S...

Descripción completa

Detalles Bibliográficos
Autores principales: Fernández-Blanco, Beatriz, Berbegall, Ana Pilar, Martin-Vañó, Susana, Castel, Victoria, Navarro, Samuel, Noguera, Rosa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Neoplasia Press 2020
Materias:
Original article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7674617/
https://www.ncbi.nlm.nih.gov/pubmed/33190090
http://dx.doi.org/10.1016/j.neo.2020.11.001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7674617/
https://www.ncbi.nlm.nih.gov/pubmed/33190090
http://dx.doi.org/10.1016/j.neo.2020.11.001

Ejemplares similares